Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Iloperidone (HP 873) 是一种D2/5-HT2受体拮抗剂,是非典型抗精神病药,可治疗精神分裂症。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
5 mg | ¥ 236 | 现货 | ||
10 mg | ¥ 423 | 现货 | ||
25 mg | ¥ 783 | 现货 | ||
50 mg | ¥ 1,150 | 现货 | ||
100 mg | ¥ 1,690 | 现货 | ||
200 mg | ¥ 2,530 | 现货 | ||
500 mg | ¥ 4,180 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 395 | 现货 |
产品描述 | Iloperidone (HP 873) is an atypical antipsychotic agent that is used for treatment of schizophrenia. |
靶点活性 | D3 receptor:7.1 nM(ki), D4 receptor:25 nM(ki) |
体外活性 | Iloperidone displays high affinity (Ki < 10 nM) for norepinephrine alpha(1)-adrenoceptors, dopamine D(3) and serotonin 5-HT(2A) receptors. [1] Iloperidone displays higher affinity for the dopamine D3 receptor (Ki = 7.1 nM) than for the dopamine D4 receptor (Ki = 25 nM). Iloperidone displays high affinity for the 5-HT6 and 5-HT7 receptors (Ki = 42.7 nM and 21.6 nM, respectively), and is found to have higher affinity for the 5-HT2A (Ki = 5.6 nM) than for the 5-HT2C receptor (Ki = 42.8 nM). [2] Iloperidone significantly increases dopa accumulation, an index of dopamine turnover in response to D2 receptor blockade, at doses from 0.3 mg/kg to 10 mg/kg i.p. in the striatum and from 1 mg/kg to 10 mg/kg in the nucleus accumbens. [3] |
体内活性 | Iloperidone exerts behavioral effects in pharmacological rats models of disrupted sensorimotor gating consistent with "atypical" antipsychotics, mediated by antagonism of dopaminergic and noradrenergic receptors. Iloperidone (1 and 3 mg/kg) prevents the PPI-disruptive effects of treatment with 1 mg/kg PCP. Iloperidone (0.3 mg/kg) prevents cirazoline-induced PPI deficits, independent of its effects on startle magnitude. [4] Iloperidone (10 mg/kg) and Melperone (10 mg/kg) produce an equivalent or a smaller increase in DA release in the nucleus accumbens (NAC) of rats, respectively, compared to the mPFC, whereas none of them increase acetylcholine (ACh) release in the NAC. [5] |
激酶实验 | Immunoblotting for the mTOR kinase assay: HEK293 cells are plated at 2-2.5×105 cells/well of a 12-well plate and serum-starved for 24 hours in DMEM. Cells are treated with increasing concentrations of Rapamycin (0.05-50 nM) for 15 minutes at 37 °C. Serum is added to a final concentration of 20% for 30 minutes at 37 °C. Cells are lysed, and cell lysates are separated by SDS-PAGE. Resolved proteins are transferred to a polyvinylidene difluoride membrane and immunoblotted with a phosphospecific primary antibody against Thr-389 of p70 S6 kinase. Data are analyzed using ImageQuant and KaleidaGr |
别名 | 伊潘立酮, HP 873 |
分子量 | 426.48 |
分子式 | C24H27FN2O4 |
CAS No. | 133454-47-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: 4 mg/mL (9.37 mM)
H2O: < 1 mg/mL (insoluble or slightly soluble)
DMSO: 26 mg/mL (61 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
Ethanol / DMSO | 1 mM | 2.3448 mL | 11.7239 mL | 23.4478 mL | 58.6194 mL |
5 mM | 0.469 mL | 2.3448 mL | 4.6896 mL | 11.7239 mL | |
DMSO | 10 mM | 0.2345 mL | 1.1724 mL | 2.3448 mL | 5.8619 mL |
20 mM | 0.1172 mL | 0.5862 mL | 1.1724 mL | 2.931 mL | |
50 mM | 0.0469 mL | 0.2345 mL | 0.469 mL | 1.1724 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Iloperidone 133454-47-4 GPCR/G Protein Neuroscience Dopamine Receptor 5-HT Receptor Adrenergic Receptor 伊潘立酮 Inhibitor 5-hydroxytryptamine Receptor HP 873 atypical HP873 Serotonin Receptor inhibit symptoms HP-873 antipsychotic schizophrenia inhibitor